Related Experiment Video
Updated: Apr 1, 2026

Fluorescence Assays for the Study of Mycobacterium tuberculosis Interaction with the Immune Receptor SLAMF1
Published on: February 28, 2025
Cathelicidin as a link between sarcoidosis and tuberculosis
Ercan Korucu1, Leyla Pur Ozyigit, Mediha Gonenc Ortakoylu
1Yedikule Chest Diseases and Surgery Education and Research Hospital, Istanbul. korucuercan@hotmail.com.
Vitamin D deficiency is common in sarcoidosis, unlike tuberculosis. Cathelicidin levels were lower in both diseases compared to controls, suggesting varied roles in granulomatous lung disease development.
Area of Science:
- Immunology
- Pulmonology
- Nutritional Science
Background:
- Sarcoidosis and tuberculosis are granulomatous lung diseases with overlapping features.
- Vitamin D's role in these conditions is under investigation.
- Cathelicidin, an antimicrobial peptide, is induced by vitamin D3.
Purpose of the Study:
- To evaluate the role of cathelicidin in the development of sarcoidosis and tuberculosis.
- To compare vitamin D and cathelicidin levels in patients with these diseases and healthy controls.
Main Methods:
- The study included 30 patients with active lung tuberculosis, 30 with sarcoidosis, and 20 healthy controls.
- Blood samples were analyzed for 25-hydroxyvitamin D [25(OH)D] and cathelicidin levels.
Main Results:
- Vitamin D levels were significantly higher in tuberculosis patients than in sarcoidosis patients.
- Severe vitamin D deficiency was prevalent in 47% of sarcoidosis patients versus 3% of tuberculosis patients.
- Cathelicidin levels were significantly lower in both sarcoidosis and tuberculosis patients compared to healthy controls, with no significant difference between the two disease groups.
Conclusions:
- Cathelicidin levels are decreased in both sarcoidosis and tuberculosis.
- Cathelicidin may play distinct roles in the pathogenesis of these granulomatous lung diseases.
- A cathelicidin cut-off value can help differentiate sarcoidosis from healthy controls.
Related Concept Videos
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...

